Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Post by moneywagonon Dec 19, 2022 10:25am
209 Views
Post# 35179480

BIOV KABOOM$$$ REVENUE GRIPPING NEWSWIRE CONGRATS INVESTORS!

BIOV KABOOM$$$ REVENUE GRIPPING NEWSWIRE CONGRATS INVESTORS!BioVaxys plans to begin stocking and distributing Immunocaps © in early 2023."
Big learning curves trading in this market, trust your dd, trust the BIOV team, stay focused. This newswire was a strong message from your BIOV team.....hold hold hold tight........revenues are in our grips!!

What's the learning curve here moneywagon?

We all know a newswire such a this would have given us a 3-5 cents share price uptick minimum, back in the days when the CA penny stocks were the favorite fruit.
This is not the case today, this is the learning curve we must all come to digest. 

No matter where you look outstanding newswires are not getting the love they USE TOO! That's a fact, this is where you dig in your boots or your heels (lol) in deeper with a tighter grip on your BIOV shares.
BIOV is going to cross the finish line...our first generating product ON SHELVES early 2023.

This newswire is the catalyst we needed to ease frustrations with PAY tience and and and this newswire should be the golden egg that gets us closer to the next increment @roaring 20's BEFORE we get that newswire!

NO WAY NOooooo way, will our share price be trading down here when product is on the shelf 2023

This is absolutely YOUR LAST CHANCE to buy down here! Lots of peeps are HOME this week ho ho ho and lots of time to find BIOV. 
Lots of casino tables to sit at BUT BUT not many tables you can sit at and be dealt a SURE Royal Flush FIRST HAND! No pumping, your shares will bare some nice fruit EARLY 2023!! Todays newswire says so!!

Best part this newswire is a PROMISE to investors, not a note of hope!! (mark that down)

Revenue generating company 2023.
Huge discovery........I repeat BIOV found Papilocare on the other side of the world in FULL BLOOM use for a decade!!

HUGE accomplishment...BIOV, getting the rights to distribute immunocaps & Papilocare, yes indeed that's the reason our money is here.

HUGE achievement....DEBT paid, prior to product distribution!! Amazing strategic planning!

There have also seen some nice swings, while we wait for distribution, we have seen 5 MILLION trade days here and when that distribution newswire gets spit out ANYTIME in early 2023.......KABOOM the moment we have been waiting for. 
Ya gotta admit it's nice to be invested in company you don't have to pump...we are simply waiting for that PROMISE to come to fruitation. Revenue generating products on the shelf early 2023! 


CHA CHA CHING.....is it 2023 yet?


<< Previous
Bullboard Posts
Next >>